Postmarketing surveillance, role of the regulatory authority of drugs.

被引：0
|
作者：
Yañez, R., V
Ortega, G. L.
Coimbra, M. R.
Pauste, I. C.
机构：
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [21] Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs
    Soh, Tracy W.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (11) : 746 - 746
  • [22] POSTMARKETING SURVEILLANCE
    DENES, G
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (23): : 373 - 375
  • [23] POSTMARKETING SURVEILLANCE OF DRUGS - THE SPONTANEOUS REPORTING SCHEME - ROLE OF THE ADVERSE-DRUG-REACTIONS-ADVISORY-COMMITTEE
    ROESER, HP
    ROHAN, AP
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (11-12) : 720 - 726
  • [24] Strategies for Postmarketing Surveillance of Drugs and Devices in Patients with ESRD Undergoing Dialysis
    Vardi, Moshe
    Yeh, Robert W.
    Herzog, Charles A.
    Winkelmayer, Wolfgang C.
    Setoguchi, Soko
    Charytan, David M.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (12): : 2213 - 2220
  • [25] Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs REPLY
    Rintoul, Angela C.
    Dobbin, Malcolm D. H.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (11) : 747 - 747
  • [26] POSTMARKETING SURVEILLANCE AND THE EXAMINATION OF THE LONG-TERM SAFETY OF ANTIULCER DRUGS
    LANGMAN, MJS
    [J]. BAILLIERES CLINICAL GASTROENTEROLOGY, 1993, 7 (01): : 183 - 190
  • [27] A CRITICAL-REVIEW ON THE METHODS OF POSTMARKETING SURVEILLANCE OF ADVERSE REACTIONS TO DRUGS
    GUT, JP
    AURICHE, M
    SPRIETPOURRA, C
    JUILLET, Y
    [J]. THERAPIE, 1985, 40 (05): : 313 - 319
  • [28] Role of metals in the cytotoxic activin of the anthracycline drugs.
    Whitehead, JP
    Gramm, EC
    Maroney, MJ
    Day, RO
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U816 - U816
  • [29] POSTMARKETING EVALUATION OF FERTILITY-REGULATING DRUGS, AS VIEWED BY REGULATORY AUTHORITIES
    HAMMERSTEIN, J
    BATTAGLINO, G
    HAMERLYNCK, J
    JENKINS, W
    REUSE, JJ
    SOBEL, S
    VONEICKSTEDT, KW
    WESTERHOLM, B
    BENAGIANO, G
    COOKE, I
    GOLDZIEHER, JW
    MAUVAISJARVIS, P
    [J]. HUMAN REPRODUCTION, 1987, 2 (01) : 45 - 58
  • [30] Postmarketing surveillance is needed
    Srinivas, VR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456): : 51 - 51
12345